Current Value
$16.901 Year Return
Current Value
$16.901 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
FENG | <0.01% | $13.64M | +68.24% | 0.00% |
SSL | -0.02% | $3.40B | -36.77% | 2.02% |
HUSA | -0.12% | $21.85M | +7.05% | 0.00% |
PRI | 0.13% | $9.75B | +28.93% | 1.12% |
MANU | -0.14% | $2.71B | -22.17% | 0.00% |
CAH | 0.14% | $30.56B | +19.71% | 1.59% |
MGPI | 0.15% | $791.42M | -60.01% | 1.33% |
CANG | 0.17% | $327.38M | +314.68% | 0.00% |
NHTC | -0.18% | $55.15M | -22.11% | 16.63% |
COR | -0.19% | $46.78B | +10.89% | 0.86% |
AXS | 0.23% | $7.55B | +62.52% | 1.94% |
LMT | -0.24% | $116.22B | +7.11% | 2.58% |
HRB | 0.30% | $7.56B | +18.18% | 2.51% |
OMCL | 0.33% | $1.97B | +30.02% | 0.00% |
MOH | 0.36% | $16.37B | -21.70% | 0.00% |
SWBI | 0.39% | $454.55M | -21.33% | 4.91% |
ETR | -0.40% | $35.16B | +65.50% | 5.55% |
WELL | 0.41% | $80.54B | +43.95% | 1.97% |
COKE | 0.44% | $12.15B | +64.47% | 0.29% |
LPLA | -0.47% | $26.13B | +45.63% | 0.34% |
Finnhub
Presenter SpeechUnknown Analyst Welcome, day 3. I hope everyone is enjoying the festivities. My name is Alex Buckley. I'm with the Healthcare Investment Banking Group at JPMorgan. And it is my...
Yahoo
The announcement follows just days after the US Centres for Disease Control confirmed its first death from the zoonotic disease.
Yahoo
SAN DIEGO, January 10, 2025--Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today announced the initiation of the Company’s Phase 1 study of ARCT-2304, a self-amplifying mRNA (sa-mRNA) vaccine candidate, also known as LUNAR-H5N1, for active immunization to prevent pandemic influenza disease caused by H
Finnhub
SAN DIEGO - Arcturus Therapeutics Holdings Inc. , a commercial messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory...
Yahoo
SAN DIEGO, January 06, 2025--Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today announced that the first CF and OTC deficiency participants initiated dosing in December 2024, in the Company’s Phase 2 multiple ascending dose studies.
Yahoo
Over the last 7 days, the United States market has experienced a 2.2% drop, yet it is up 24% over the past year with earnings forecast to grow by 15% annually. In this context of fluctuating yet promising growth, identifying high-growth tech stocks such as Arcturus Therapeutics Holdings requires an understanding of their potential to capitalize on technological advancements and market opportunities amidst these dynamic conditions.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PULM | -13.27% | $22.32M | +245.20% | 0.00% |
CBOE | -12.82% | $20.39B | +5.07% | 1.21% |
K | -12.33% | $28.19B | +51.64% | 2.76% |
STG | -10.57% | $30.93M | -32.61% | 0.00% |
TSN | -10.40% | $19.45B | +4.92% | 3.54% |
CL | -10.15% | $72.46B | +10.34% | 2.24% |
PEP | -9.29% | $203.40B | -10.57% | 3.59% |
GIS | -8.57% | $32.87B | -5.57% | 3.99% |
CYCN | -7.91% | $8.10M | -16.36% | 0.00% |
CPB | -7.69% | $11.62B | -9.66% | 3.85% |
KR | -7.57% | $42.23B | +27.04% | 2.08% |
MMC | -7.25% | $105.70B | +8.10% | 1.42% |
TPB | -7.01% | $1.02B | +135.12% | 0.48% |
CME | -6.55% | $83.86B | +15.17% | 4.45% |
CAG | -6.14% | $12.32B | -9.78% | 5.42% |
CHD | -6.06% | $26.08B | +9.84% | 1.06% |
PG | -6.01% | $379.47B | +9.19% | 2.45% |
ALL | -5.99% | $50.02B | +21.97% | 1.93% |
WRB | -5.60% | $22.67B | +21.51% | 0.65% |
FLUT | -5.58% | $46.84B | +31.82% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ABCL | 47.86% | $877.24M | -43.32% | 0.00% |
CORT | 42.10% | $5.80B | +126.49% | 0.00% |
CVAC | 41.21% | $919.65M | +12.64% | 0.00% |
BEAM | 41.01% | $1.94B | -1.06% | 0.00% |
INSM | 40.95% | $12.97B | +158.96% | 0.00% |
RXRX | 40.16% | $2.55B | -32.19% | 0.00% |
DMRC | 39.59% | $885.53M | +14.29% | 0.00% |
CRSP | 39.34% | $3.46B | -34.62% | 0.00% |
SPCE | 39.10% | $148.71M | -86.59% | 0.00% |
AGIO | 39.08% | $1.85B | +49.19% | 0.00% |
PGEN | 38.32% | $325.08M | -13.28% | 0.00% |
BNTX | 37.96% | $26.83B | +13.96% | 0.00% |
ALEC | 37.61% | $167.46M | -70.92% | 0.00% |
TWST | 37.53% | $2.83B | +41.55% | 0.00% |
ALLO | 37.04% | $381.60M | -41.10% | 0.00% |
DNLI | 35.94% | $3.16B | +28.32% | 0.00% |
KRYS | 35.94% | $4.27B | +15.51% | 0.00% |
GPRO | 35.55% | $162.50M | -66.45% | 0.00% |
CRBU | 35.53% | $138.55M | -70.12% | 0.00% |
ADPT | 35.43% | $1.01B | +65.29% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
ARKG | 53.07% | $1.10B | 0.75% |
XBI | 51.74% | $6.10B | 0.35% |
IBB | 46.44% | $6.26B | 0.45% |
GNOM | 45.65% | $67.06M | 0.5% |
PBW | 44.98% | $306.60M | 0.65% |
QQA | 43.37% | $147.14M | 0% |
XPH | 42.97% | $165.13M | 0.35% |
RSPA | 42.71% | $274.39M | 0% |
FBT | 42.58% | $1.17B | 0.56% |
PTH | 41.76% | $119.40M | 0.6% |
PBE | 41.53% | $250.32M | 0.58% |
IWC | 41.33% | $960.97M | 0.6% |
IWO | 40.01% | $12.85B | 0.24% |
EFAA | 39.80% | $104.39M | 0% |
PBD | 39.71% | $79.80M | 0.75% |
EDOC | 39.40% | $38.10M | 0.68% |
KOMP | 39.13% | $2.14B | 0.2% |
BBH | 38.61% | $391.30M | 0.35% |
ERTH | 38.50% | $148.74M | 0.67% |
VBK | 38.33% | $20.10B | 0.07% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -17.84% | $195.31M | 0.85% |
USDU | -16.71% | $397.27M | 0.5% |
UUP | -12.74% | $642.45M | 0.77% |
TAIL | -8.04% | $65.49M | 0.59% |
JUCY | -7.66% | $300.65M | 0.6% |
TPMN | -7.51% | $34.33M | 0.65% |
CTA | -6.43% | $555.39M | 0.76% |
XBIL | -5.64% | $648.37M | 0.15% |
BIL | -5.14% | $36.98B | 0.1356% |
TBIL | -5.06% | $4.84B | 0.15% |
SGOV | -4.93% | $31.69B | 0.09% |
UNG | -4.75% | $852.27M | 1.06% |
EQLS | -4.41% | $9.14M | 1% |
CLOI | -4.01% | $810.07M | 0.4% |
MINT | -3.54% | $12.13B | 0.35% |
MSOS | -3.21% | $447.20M | 0.83% |
DBE | -1.78% | $51.45M | 0.77% |
CCOR | -1.57% | $83.28M | 1.18% |
SHV | -1.35% | $19.02B | 0.15% |
DBA | -1.29% | $807.60M | 0.93% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
DBO | -0.01% | $219.60M | 0.77% |
IYK | 0.10% | $1.23B | 0.4% |
BOXX | 0.21% | $4.77B | 0.1949% |
KRBN | -0.35% | $192.50M | 0.85% |
ULST | 0.69% | $554.46M | 0.2% |
BILZ | 0.80% | $633.27M | 0.14% |
BILS | 0.83% | $3.36B | 0.1356% |
DUSB | -1.07% | $944.69M | 0.15% |
FLRN | 1.14% | $2.53B | 0.15% |
DBA | -1.29% | $807.60M | 0.93% |
SHV | -1.35% | $19.02B | 0.15% |
XHLF | 1.45% | $945.68M | 0.03% |
SOYB | 1.49% | $26.94M | 0.22% |
CCOR | -1.57% | $83.28M | 1.18% |
CNBS | 1.59% | $11.67M | 0.77% |
DBE | -1.78% | $51.45M | 0.77% |
CORN | 2.42% | $64.82M | 0.2% |
KMLM | 2.49% | $328.91M | 0.9% |
IBTF | 2.57% | $2.23B | 0.07% |
GBIL | 2.63% | $5.81B | 0.12% |